EcoDrugPlus

Tyrosine-Protein Kinase Itk/tsk-Like

Ensembl ID : ENSECRG00000017264
Gene Symbol: LOC114660408
3 Cross references
208 Possible Orthologues:

Ubiquitin-Like Protein Fubi

Ensembl ID : ENSECRG00000018432
Gene Symbol: LOC114666740
2 Cross references
286 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSECRG00000023063
Gene Symbol: UTS2R
3 Cross references
91 Possible Orthologues:

Utrophin

Ensembl ID : ENSECRG00000000888
Gene Symbol: UTRN
2 Cross references
269 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSECRG00000002185
Gene Symbol: VEGFA
3 Cross references
254 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSECRG00000015251
Gene Symbol: VDR
3 Cross references
467 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1-Like Protein 1

Ensembl ID : ENSECRG00000022907
Gene Symbol: LOC114661729
3 Cross references
191 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1c-Like

Ensembl ID : ENSECRG00000021841
Gene Symbol: LOC114668806
3 Cross references
215 Possible Orthologues:

Voltage-Dependent R-Type Calcium Channel Subunit Alpha-1e-Like

Ensembl ID : ENSECRG00000007998
Gene Symbol: LOC114659767
2 Cross references
295 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSECRG00000022673
Gene Symbol: LOC114666865
3 Cross references
244 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-7 Subunit-Like

Ensembl ID : ENSECRG00000022666
Gene Symbol: LOC114666661
3 Cross references
257 Possible Orthologues:

Ensembl ID : ENSECRG00000006562
Gene Symbol: -
Cross references: -
252 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).